Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Apalutamide

A non-steroidal antiandrogen that blocks the androgen receptor, preventing testosterone from stimulating prostate cancer cells. Approved in the United States in 2018, it is used in advanced prostate cancer. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It was the first medicine approved by the FDA for non-metastatic castration-resistant prostate cancer, and the first approval based on 'metastasis-free survival'.

ApalutamideGo to the active ingredient →
ApalutamideActive ingredientApalutamideCat. No. P-A169-001CAS 956104-40-8
Apalutamide-D7Isotopically labelledApalutamide-D7Cat. No. P-A169-003CAS 1638885-75-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.